Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Nordhealth AS's Enterprise Value is kr1,642.0 Mil.
Nordhealth AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was kr-166.6 Mil. Therefore, Nordhealth AS's EV-to-EBIT ratio for today is -9.86.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Nordhealth AS's Enterprise Value is kr1,642.0 Mil.
Nordhealth AS's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was kr-33.6 Mil. Therefore, Nordhealth AS's EV-to-EBITDA ratio for today is -48.86.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Nordhealth AS's Enterprise Value is kr1,642.0 Mil.
Nordhealth AS's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was kr599.2 Mil. Therefore, Nordhealth AS's EV-to-Revenue ratio for today is 2.74.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Nordhealth AS's Enterprise Value is kr1,642.0 Mil.
Nordhealth AS's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was kr-77.8 Mil. Therefore, Nordhealth AS's EV-to-FCF ratio for today is -21.11.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Nordhealth AS (OSL:NORDH) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Nordhealth AS's current Enterprise Value is kr1,642.0 Mil.
Nordhealth AS's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-166.6 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Nordhealth AS's current Enterprise Value is kr1,642.0 Mil.
Nordhealth AS's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-33.6 Mil.
Nordhealth AS's current Enterprise Value is kr1,642.0 Mil.
Nordhealth AS's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr599.2 Mil.
Nordhealth AS's current Enterprise Value is kr1,642.0 Mil.
Nordhealth AS's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-18.7 Mil.
Nordhealth AS's current Enterprise Value is kr1,642.0 Mil.
Nordhealth AS's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-77.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nordhealth AS Enterprise Value Related Terms
Nordhealth AS Enterprise Value Historical Data
* Premium members only.
The historical data trend for Nordhealth AS's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:NORDH vs VEEV, BTSG, TEM: Enterprise Value Comparison
For the Health Information Services subindustry, Nordhealth AS's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nordhealth AS Enterprise Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nordhealth AS's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Nordhealth AS's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Nordhealth AS's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of kr1,642.0 Mil mean?
Nordhealth AS (OSL:NORDH) has a Enterprise Value of kr1,642.0 Mil as of Jul. 12, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Nordhealth AS and its competitors.
Is Nordhealth AS's Enterprise Value too high?
Nordhealth AS's current Enterprise Value is kr1,642.0 Mil. Overall, Nordhealth AS has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nordhealth AS's Enterprise Value compare to VEEV and BTSG?
Nordhealth AS's Enterprise Value of kr1,642.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Healthcare Providers & Services company?
A good Enterprise Value depends on the Healthcare Providers & Services industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Nordhealth AS and its competitors. Nordhealth AS's current Enterprise Value is kr1,642.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nordhealth AS stock overvalued right now?
Based on GuruFocus' analysis, Nordhealth AS (OSL:NORDH) is currently considered Significantly Undervalued. The stock's GF Value™ is kr39.07, compared to a current price of kr23.00 — trading 41.1% below its estimated fair value. The current Enterprise Value is kr1,642.0 Mil. Nordhealth AS's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Nordhealth AS (OSL:NORDH), the current Enterprise Value is kr1,642.0 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nordhealth AS (OSL:NORDH) Overvalued in 2026?
Based on GuruFocus' analysis, Nordhealth AS stock appears to be undervalued.
The current stock price of kr23.00 is trading 41.1% below its estimated GF Value™ of kr39.07.
GuruFocus considers Nordhealth AS to be Significantly Undervalued.
Key valuation signals for OSL:NORDH:
Enterprise Value: kr1,642.0 Mil
GF Value™: kr39.07 vs. price of kr23.00 (41.1% below fair value)
No single metric tells the full story. See the OSL:NORDH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nordhealth AS is a cloud-based healthcare Software-as-a-Service business. Its flagship Practice Management Software (PMS), Provet for veterinary practices and Therapy Unified Platform for therapy practices, assist healthcare professionals to streamline operations and improve patient care. The majority of its revenue is generated through software subscriptions. The Group also offers additional services related to the implementation of the SaaS systems, including consultancy services, education, and data conversion. Its operating segments are: Veterinary, which generates the majority of revenue, Therapy, and Other. Geographically, Nordhealth derives maximum revenue from Norway, and the rest from Finland, the United Kingdom, Sweden, Denmark, the DACH region, and other countries.
76GF Score
Get the complete analysis for OSL:NORDH
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:NORDH has been successfully added to your 
